Atormac
brintellex
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 5642  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
   Navigate here  
  »   Search
  »   Current Issue
  »   Submit Article 
  »   My Preferences 

Follow us on:

Twitter Icon Linkedin Icon Instagram Icon Facebook Icon

 


This article has been cited by
1Effects of CYP2C9*1/*3 genotype on the pharmacokinetics of flurbiprofen in Korean subjects
Yun-Jeong Lee,Ji-Yeong Byeon,Young-Hoon Kim,Se-Hyung Kim,Chang-Ik Choi,Jung-Woo Bae,Uy-Dong Sohn,Choon-Gon Jang,Jeongmi Lee,Seok-Yong Lee
Archives of Pharmacal Research.2015;38(6)1232
[DOI]
2Implications of pharmacogenetics for the therapeutic use of antiepileptic drugs
Chiara Piana,Natalicia de Jesus Antunes,Oscar Della Pasqua
Expert Opinion on Drug Metabolism & Toxicology.2014;10(3)341
[DOI]
3Effects of Cytochrome P450 2C9 Polymorphism on Bosentan Metabolism
Mengchun Chen,Youting Zhang,Peipei Pan,Li Wang,Yunyun Zhan,Hui Jin,Mengmin Xia,Xianqin Wang,Dapeng Dai,Jianping Cai,Guoxin Hu
Drug Metabolism and Disposition.2014;42(11)1820
[DOI]
4Effects of Cytochrome P450 2C9 Polymorphism on Bosentan Metabolism
Jules Beal
Drug Metabolism and Disposition.2014;36(11)85
[DOI]
5Effects of Cytochrome P450 2C9 Polymorphism on Bosentan Metabolism
Umamaheswaran Gurusamy,Deepak Gopal Shewade
Drug Metabolism and Disposition.2014;36(11)1037
[DOI]
6VKORC1 and CYP2C9 genotype distribution in Asian countries
Tejasvita Gaikwad,Kanjaksha Ghosh,Shrimati Shetty
Thrombosis Research.2014;134(3)537
[DOI]
7Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region
Renée Dagenais,Kyle John Wilby,Hazem Elewa,Mary H. H. Ensom
Drugs in R&D.2017;17(3)341
[DOI]
8Impact of CYP2C9 Polymorphism Found in the Chinese Population on the Metabolism of Propofol in Vitro
Qing-Quan Lian,Pei-Pei Pan,Jun-Wei Li,Han Lin,Guo-Xin Hu,Ming-Zhang Zuo,Jian-Ping Cai
Biological & Pharmaceutical Bulletin.2015;38(4)531
[DOI]
9CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects
Valentina Franco,Emilio Perucca
Expert Opinion on Drug Metabolism & Toxicology.2015;11(8)1269
[DOI]
10A prospective study to assess the association between genotype, phenotype and Prakriti in individuals on phenytoin monotherapy
Saket J. Thaker,Prajakta P. Gandhe,Charuta J. Godbole,Shital R. Bendkhale,Nitin B. Mali,Urmila M. Thatte,Nithya J. Gogtay
Journal of Ayurveda and Integrative Medicine.2017;8(1)37
[DOI]
11CYP2C9 Variations and Their Pharmacogenetic Implications Among Diverse South Asian Populations
Sheikh Nizamuddin,Shivendra Dubey,Sakshi Singh,Saurav Sharma,Pratheusa Machha,Kumarasamy Thangaraj
Pharmacogenomics and Personalized Medicine.2021;Volume 14(1)135
[DOI]
12Pharmacogenetics of antiepileptic drug-induced hypersensitivity
Katarzyna M Bloch,Graeme J Sills,Munir Pirmohamed,Ana Alfirevic
Pharmacogenomics.2014;15(6)857
[DOI]
Online since 20th March '04
Published by Wolters Kluwer - Medknow